Haifeng Wu
- Immunology top 1%
- Nephrology top 0.5%
- Hematology top 1%
- Molecular Biology top 10%
- Genetics top 1%
- Co-authors
- Spero R. CatalandMing JinBrad H. RovinLee A. HebertTibor NádasdyGyongyi NadasdyShangbin YangMarie Scully
- Topics
- Complement system in diseases (33 papers)Renal Diseases and Glomerulopathies (18 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers)
- Cited by
- NephrologyImmunologyHematology
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Haifeng Wu
83 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Immunology 2.1k
- Nephrology 1.1k
- Hematology 963
- Molecular Biology 778
- Genetics 633
Countries citing papers authored by Haifeng Wu
This map shows the geographic impact of Haifeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haifeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haifeng Wu more than expected).
Fields of papers citing papers by Haifeng Wu
This network shows the impact of papers produced by Haifeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haifeng Wu. The network helps show where Haifeng Wu may publish in the future.
Co-authorship network of co-authors of Haifeng Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Haifeng Wu. A scholar is included among the top collaborators of Haifeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haifeng Wu. Haifeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 255 | |
| 2 | 14 | |
| 3 | Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpurabreakdown → | 429 |
| 4 | 18 | |
| 5 | 16 | |
| 6 | 60 | |
| 7 | 35 | |
| 8 | 12 | |
| 9 | 45 | |
| 10 | 223 | |
| 11 | 92 | |
| 12 | 98 | |
| 13 | 28 | |
| 14 | 118 | |
| 15 | 56 | |
| 16 | 19 | |
| 17 | 19 | |
| 18 | 84 | |
| 19 | 18 | |
| 20 | 47 |
About Haifeng Wu
Haifeng Wu is a scholar working on Nephrology, Immunology and Hematology, having authored 86 papers that have together received 3.6k indexed citations. Recurring topics across this work include Complement system in diseases (33 papers), Renal Diseases and Glomerulopathies (18 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers). The work is most often cited by research in Nephrology (1.1k citations), Immunology (2.1k citations) and Hematology (963 citations). Haifeng Wu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Spero R. Cataland, Ming Jin, Brad H. Rovin, Lee A. Hebert, Tibor Nádasdy, Gyongyi Nadasdy, Shangbin Yang, Marie Scully, Flora Peyvandi and Bingyu Liu. Their work appears in journals such as New England Journal of Medicine, Blood and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.